Notice2024-16020
National Institute on Drug Abuse; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 22, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 140 (Monday, July 22, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 140 (Monday, July 22, 2024)]
[Notices]
[Pages 59123-59124]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16020]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 59124]]
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Pharmacokinetic Analysis Resource Center.
Date: August 14, 2024.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Meysam Yazdankhah, Ph.D., Scientific Review
Officer, National Institutes of Health, National Institute on Drug
Abuse, Scientific Review Branch, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 402-6965, <a href="/cdn-cgi/l/email-protection#a1ccc4d8d2c0cc8fd8c0dbc5c0cfcac9c0c9e1cfc8c98fc6ced7"><span class="__cf_email__" data-cfemail="d6bbb3afa5b7bbf8afb7acb2b7b8bdbeb7be96b8bfbef8b1b9a0">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: July 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-16020 Filed 7-19-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 22, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.